Overview
Indium has been used in trials studying the basic science of Clear Cell Renal Cell Carcinoma.
Indication
No indication information available.
Associated Conditions
No associated conditions information available.
Clinical Trials
Title | Posted | Study ID | Phase | Status | Sponsor |
|---|---|---|---|---|---|
2024/03/01 | Phase 1 | Recruiting | City of Hope Medical Center | ||
2022/05/05 | Phase 1 | Recruiting | City of Hope Medical Center | ||
2021/12/01 | Phase 1 | Active, not recruiting | City of Hope Medical Center | ||
2005/09/16 | Phase 1 | Completed |
FDA Drug Approvals
Approved Product | Manufacturer | NDC Code | Route | Strength | Effective Date |
|---|---|---|---|---|---|
| Deseret Biologicals, Inc. | 43742-1312 | ORAL | 12 [hp_X] in 1 mL | 5/27/2025 | |
| Dr. Donna Restivo DC | 62185-0062 | ORAL | 12 [hp_X] in 1 mL | 5/23/2025 |
EMA Drug Approvals
Approved Product | Authorization Holder | Status | Issued Date |
|---|---|---|---|
| No EMA approvals found for this drug. | |||
HSA Drug Approvals
Approved Product | Manufacturer | Approval Number | Dosage Form | Strength | Approval Date |
|---|---|---|---|---|---|
| OCTREOSCAN FOR INJECTION | SIN11244P | INJECTION, POWDER, FOR SOLUTION | 122 MBq/1.1 ml (in vial A) | 12/16/1999 | |
| INDIUM (In111) CHLORIDE INJECTION 370 MBq/ml | SIN10571P | INJECTION | 370 MBq/ml at ART | 12/22/1998 |
NMPA Drug Approvals
Approved Product | Company | Approval Number | Drug Type | Dosage Form | Approval Date |
|---|---|---|---|---|---|
| No NMPA approvals found for this drug. | |||||
PPB Drug Approvals
Approved Product | Registration No. | Company | Licence No. | Strength | Registration Date |
|---|---|---|---|---|---|
| No PPB approvals found for this drug. | |||||
TGA Drug Approvals
Approved Product | ARTG ID | Sponsor | Registration Type | Status | Registration Date |
|---|---|---|---|---|---|
| No TGA approvals found for this drug. | |||||
Help Us Improve
Your feedback helps us provide better drug information and insights.